Machine learning is ushering in a new era of medicine, e.g., by predicting the shape of therapeutic drugs and assisting in their design. Witty Prof. Charlotte Deane of the University of Oxford and Exscientia explains how.
Charlotte:
• Is a global-leading expert on using ML for designing therapeutic drugs.
• Has been faculty at the University of Oxford for over 20 years, where serves as Professor of Structural Bioinformatics and heads the 25-person Protein Informatics Lab.
• Is Chief Scientist Biologics A.I. at Exscientia, a NASDAQ-listed pharmatech company that uses computational approaches to drive drug development in a fraction of the time of traditional drug companies.
• Was COVID-Response Director for UK Research and Innovation, resulting in Queen Elizabeth II honoring her as a Member of the Most Excellent Order of the British Empire.
Today’s episode should appeal to technical and non-technical folks alike as it features an absolutely brilliant scientist and communicator describing how we can use A.I. to speed the discovery of new molecules that help our body fight off ailments as diverse as viruses and cancer.
In this episode, Prof. Deane details:
• How your immune system works.
• What biologics are and why they’re such an important class of drugs.
• What’s holding back the widespread use of precision medicines that are pinpoint-customized to a specific tumor in a specific person.
• What the celebrated AlphaFold algorithm does exquisitely and where it (and all other computational models of protein folding) still need to improve.
• How she used data to marshall the UK’s scientific response to Covid.
• How data and machine learning will transform drug development over the coming years.
The SuperDataScience podcast is available on all major podcasting platforms, YouTube, and at SuperDataScience.com.